CD8A and melanoma: Research has shown that reduced expression of the nuclear factor erythroid 2-related factor 2 (NRF2) signaling pathway can significantly increase infiltration of CD8+ and CD4+ T cell into tumors, inhibit melanoma growth, and decrease PD-L1 expression.